A Study of Volociximab in Metastatic Melanoma

Update Il y a 4 ans
Reference: NCT00369395

Woman and Man

Extract

This is a Phase 2, multicenter, research study determining the effects of an investigational drug called volociximab in metastatic melanoma. The purpose of the study is to compare the clinical benefit and safety of volociximab. Pharmacokinetics and mechanism of action will also be evaluated.


Inclusion criteria

  • Stage IV Melanoma

Links